Asst Degli Spedali Civili Di Brescia
11
5
6
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Role: collaborator
Gepant treAtments: EffectIveNess and tolERability (GAINER)
Role: collaborator
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Role: collaborator
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Role: collaborator
Ditan Acute tReatments: Effectiveness and Tolerability (DART)
Role: collaborator
Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome
Role: collaborator
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
Role: collaborator
Non Inferiority KawasakI Trial With Anakinra
Role: collaborator
The Effects of a Multimodal Approach for the Treatment of PPA
Role: collaborator
Effectiveness and Tolerability of Eptinezumab
Role: collaborator
Genetic Bases of COVID-19 Clinical Variability
Role: collaborator
All 11 trials loaded